Generation of Transplantable Beta Cells for Patient-Specific Cell Therapy
Islet cell transplantation offers a potential cure for type 1 diabetes, but it is challenged by insufficient donor tissue and side effects of current immunosuppressive drugs. Therefore, alternative sources of insulin-producing cells and isletfriendly immunosuppression are required to increase the ef...
Saved in:
Main Authors: | Xiaojie Wang, Daniel L. Metzger, Mark Meloche, Jianqiang Hao, Ziliang Ao, Garth L. Warnock |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2012/414812 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
B7-H4 Pathway in Islet Transplantation and β-Cell Replacement Therapies
by: Xiaojie Wang, et al.
Published: (2011-01-01) -
γδ T Cells’ Role in Donor-Specific Antibody Generation: Insights From Transplant Recipients and Experimental Models
by: Xavier Charmetant, et al.
Published: (2025-01-01) -
Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy
by: Joselyn Rojas, et al.
Published: (2018-01-01) -
Evolution of 𝜷-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation
by: Cyrus Jahansouz, et al.
Published: (2011-01-01) -
Improving Cytomegalovirus-Specific T Cell Reconstitution after Haploidentical Stem Cell Transplantation
by: Xiao-Hua Luo, et al.
Published: (2014-01-01)